| Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity B Meng, A Abdullahi, IATM Ferreira, N Goonawardane, A Saito, I Kimura, ... Nature 603 (7902), 706-714, 2022 | 877 | 2022 |
| Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation A Saito, T Irie, R Suzuki, T Maemura, H Nasser, K Uriu, Y Kosugi, ... Nature 602 (7896), 300-306, 2022 | 498 | 2022 |
| SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity C Motozono, M Toyoda, J Zahradnik, A Saito, H Nasser, TS Tan, I Ngare, ... Cell host & microbe 29 (7), 1124-1136. e11, 2021 | 490 | 2021 |
| Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation H Inagaki, A Saito, H Sugiyama, T Okabayashi, S Fujimoto Emerging Microbes & Infections 9 (1), 1744-1747, 2020 | 313 | 2020 |
| Virological characteristics of the SARS-CoV-2 Omicron BA. 2 spike D Yamasoba, I Kimura, H Nasser, Y Morioka, N Nao, J Ito, K Uriu, ... Cell 185 (12), 2103-2115. e19, 2022 | 266 | 2022 |
| Virological characteristics of the SARS-CoV-2 Omicron BA. 2 subvariants, including BA. 4 and BA. 5 I Kimura, D Yamasoba, T Tamura, N Nao, T Suzuki, Y Oda, S Mitoma, J Ito, ... Cell 185 (21), 3992-4007. e16, 2022 | 230 | 2022 |
| Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants T Tamura, J Ito, K Uriu, J Zahradnik, I Kida, Y Anraku, H Nasser, M Shofa, ... Nature communications 14 (1), 2800, 2023 | 206 | 2023 |
| The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance I Kimura, Y Kosugi, J Wu, J Zahradnik, D Yamasoba, EP Butlertanaka, ... Cell reports 38 (2), 2022 | 194 | 2022 |
| SARS-CoV-2 B. 1.617 mutations L452R and E484Q are not synergistic for antibody evasion IATM Ferreira, SA Kemp, R Datir, A Saito, B Meng, P Rakshit, ... The Journal of infectious diseases 224 (6), 989-994, 2021 | 151 | 2021 |
| Virological characteristics of the SARS-CoV-2 Omicron BA. 2.75 variant A Saito, T Tamura, J Zahradnik, S Deguchi, K Tabata, Y Anraku, I Kimura, ... Cell host & microbe 30 (11), 1540-1555. e15, 2022 | 118 | 2022 |
| SARS-CoV-2 Omicron spike mediated immune escape and tropism shift B Meng, IATM Ferreira, A Abdullahi, N Goonawardane, A Saito, I Kimura, ... BioRxiv, 2021.12. 17.473248, 2021 | 103 | 2021 |
| Roles of capsid-interacting host factors in multimodal inhibition of HIV-1 by PF74 A Saito, D Ferhadian, GA Sowd, E Serrao, J Shi, UD Halambage, S Teng, ... Journal of virology 90 (12), 5808-5823, 2016 | 92 | 2016 |
| Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ. 1.1 variant J Ito, R Suzuki, K Uriu, Y Itakura, J Zahradnik, KT Kimura, S Deguchi, ... Nature communications 14 (1), 2671, 2023 | 89 | 2023 |
| Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity T Omatsu, ML Moi, T Hirayama, T Takasaki, S Nakamura, S Tajima, M Ito, ... Journal of general virology 92 (10), 2272-2280, 2011 | 88 | 2011 |
| Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA. 2.86 variant K Uriu, J Ito, Y Kosugi, YL Tanaka, Y Mugita, Z Guo, AA Hinay, O Putri, ... The Lancet Infectious Diseases 23 (11), e460-e461, 2023 | 81 | 2023 |
| Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo R Furuta, J Yasunaga, M Miura, K Sugata, A Saito, H Akari, T Ueno, ... PLoS pathogens 13 (11), e1006722, 2017 | 69 | 2017 |
| Discovery of a small molecule inhibitor targeting dengue virus NS5 RNA-dependent RNA polymerase H Shimizu, A Saito, J Mikuni, EE Nakayama, H Koyama, T Honma, ... PLoS neglected tropical diseases 13 (11), e0007894, 2019 | 66 | 2019 |
| Capsid-CPSF6 Interaction Is Dispensable for HIV-1 Replication in Primary Cells but Is Selected during Virus Passage In Vivo A Saito, MS Henning, E Serrao, BN Dubose, S Teng, J Huang, X Li, ... Journal of virology 90 (15), 6918-6935, 2016 | 66 | 2016 |
| Improved capacity of a monkey-tropic HIV-1 derivative to replicate in cynomolgus monkeys with minimal modifications A Saito, M Nomaguchi, S Iijima, A Kuroishi, T Yoshida, YJ Lee, ... Microbes and Infection 13 (1), 58-64, 2011 | 50 | 2011 |
| Virological characteristics of the novel SARS-CoV-2 Omicron variants including BA. 2.12. 1 I Kimura, D Yamasoba, T Tamura, N Nao, Y Oda, S Mitoma, J Ito, ... BA 4, 2022.2005, 2022 | 48 | 2022 |
